Related Experiment Video

Updated: May 31, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010

Diana Averbuch1, Carlos Hidalgo-Grass, Allon E Moses

  • 1Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Emerging Infectious Diseases
|July 14, 2011
PubMed

Insights

Macrolide resistance in Mycoplasma pneumoniae, previously rare outside Asia, has emerged in Israel. This study documents its in vivo evolution during pneumonia treatment in a child.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Macrolide resistance in Mycoplasma pneumoniae is a growing global concern.
  • Historically, high rates of resistance are concentrated in Asian countries.
  • Limited data exists on macrolide resistance emergence in other geographical regions.

Purpose of the Study:

  • To report the emergence of macrolide-resistant Mycoplasma pneumoniae in Israel.
  • To investigate the in vivo evolution of macrolide resistance during treatment.
  • To understand the clinical implications of emerging resistance.

Main Methods:

  • Clinical case study of a pediatric patient with pneumonia.
  • Microbiological analysis of Mycoplasma pneumoniae isolates.
  • Genetic analysis to identify resistance mechanisms.

Main Results:

  • Detection of macrolide-resistant Mycoplasma pneumoniae in Israel, a new geographical emergence.
  • Observation of the in vivo development and potential selection of resistance during antibiotic therapy.
  • Identification of specific genetic mutations associated with macrolide resistance.

Conclusions:

  • Macrolide resistance in Mycoplasma pneumoniae is no longer confined to Asia.
  • In vivo evolution of resistance highlights the need for careful monitoring during treatment.
  • This emergence necessitates updated diagnostic and treatment guidelines for Mycoplasma pneumoniae infections.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antibiotic Selection00:57

Antibiotic Selection

Overview